X
skip to main content
Logo
  • October 18, 2017

    A pan-Canadian team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with significantly greater accuracy than other leading models. This Terry Fox Research Institute study suggests the team’s innovative approach could be considered for use in lung cancer screening programs both in Canada and around the world.

  • September 18, 2017

    The annual Terry Fox Research Institute Ontario Node Symposium is just around the corner, and will be held on Dec. 4, 2017 at at the the MaRS Discovery Centre in Toronto.

  • September 06, 2017

    TFRI is pleased to announce that it will be presenting a concurrent session (D6 in program) at the upcoming Canadian Cancer Research Conference featuring talks by four outstanding Canadian investigators: Dr. John Bell (OHRI) Dr. John Dick (UHN), Dr. Stephen Lam (BC Cancer Agency), and Dr. Marco Marra (BC Cancer Agency).

  • September 06, 2017

    TFRI’s one-day 8th Annual Scientific Meeting on Saturday, Nov. 4 in Vancouver will feature talks related to the theme of the potential of precision medicine. There will be three plenaries on the subjects of cancer biology, prognostic strategies and therapeutic strategies.

  • September 06, 2017

    The annual Terry Fox Run is just around the corner and our purple-shirted research teams, their friends and families will be out in full force again this year! To date more than 16 teams have confirmed their participation in the upcoming run on Sunday, Sept. 17th.

  • September 06, 2017

    A new study has analyzed hundreds of sequenced medulloblastoma (MB) samples, identifying new targets that could give children with this disease less harmful therapeutic options.

  • September 06, 2017

    A recent study by a prolific TFRI-funded team has demonstrated that disrupting ERG transcriptional activity is sufficient to suppress the major characteristics of ERG-transformed prostate cancers.

  • September 06, 2017

    Ontario cancer researchers have found that an oncolytic virus may lead to a promising new therapy option for patients with peritoneal carcinomatosis, a disseminated intra-abdominal tumour.

  • September 06, 2017

    Diffuse optical spectroscopic texture features can predict breast cancer response to neoadjuvant chemotherapy in locally advanced breast cancer patients before therapy even begins.

  • September 06, 2017

    A team of Canadian cancer researchers has shown that rare, therapy-resistant leukemia stem cells are already present at diagnosis in patients who experience relapses of acute myeloid leukemia (AML).

  • September 06, 2017

    While significant accolades are given to scientists who discover genetic mutations that are linked to cancer, it is equally important to determine factors that are not correlated.

  • September 06, 2017

    Subtype-specific alterations in a driver gene for non-Hodgkin lymphoma (BCL2) is strongly associated with poor patient outcomes after treatment.

  • September 06, 2017

    The discovery of seven new genetic subtypes of ovarian cancer may lead to targeted treatments for women diagnosed with this disease, including those with the most malignant form.

  • September 05, 2017

    The Terry Fox Research Institute has invested nearly $21.5-million to renew three 2017 Terry Fox New Frontiers Program Project Grants (PPGs).

  • August 28, 2017

    This year's annual Terry Fox Run will be held at locations across Canada on Sunday, Sept. 17. Everyone is welcome to participate, regardless of age, athletic ability or socio-economic standing.

Back to Top